Except for the amendments regarding the administrative and minor changes, all other information included in the summary of product characteristics of ‘C(M)IT/MIT & Glutaraldehyde Formulations’ as set out in the Annex to Implementing Regulation (EU) 2025/807 remains unchanged.
Recital 8, Regulation (EU) 2026/1311
In forcesince 15 Jun 2026